DOC - Physicians Realty Trust
NYSE
->
Real Estate
->
REIT—Healthcare Facilities
Milwaukee,
United States
Type: Equity
DOC price evolution
DOC
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $159.29 | $157.16 | $156.78 | |
| Short term investments | ||||
| Net receivables | $64.98 | $59.66 | $68.57 | $11.96 |
| Inventory | ||||
| Total current assets | $245.41 | $166.54 | $170.33 | $274.51 |
| Long term investments | ||||
| Property, plant & equipment | $16320.12 | $16838.43 | $17097 | $4834.33 |
| Goodwill & intangible assets | $1076.09 | $1160.45 | $314.16 | |
| Total noncurrent assets | ||||
| Total investments | $1202.68 | $1198.36 | $1001.3 | |
| Total assets | $19969.77 | $20179.71 | $20542.04 | $5155.62 |
| Current liabilities | ||||
| Accounts payable | $1079.62 | $709.22 | $717.19 | $8.36 |
| Deferred revenue | $907.85 | $923.68 | $905.63 | |
| Short long term debt | ||||
| Total current liabilities | $1593.86 | $1515.71 | $1522.97 | $270.48 |
| Long term debt | $8555.89 | $8574.46 | $8726.17 | $1973.04 |
| Total noncurrent liabilities | ||||
| Total debt | $8916.5 | $9062.91 | $2077.88 | |
| Total liabilities | $11406.93 | $10760.94 | $10942.54 | $2266.09 |
| Shareholders' equity | ||||
| Retained earnings | -$4968.82 | -$4844.68 | -$4779.6 | -$1061.29 |
| Other shareholder equity | -$12.38 | $42.3 | $38.54 | $0.72 |
| Total shareholder equity | $8757.5 | $8881.61 | $2763.53 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $156.78 | $7.73 | $9.88 | $2.52 |
| Short term investments | ||||
| Net receivables | $11.96 | $112.81 | $4.95 | $4.76 |
| Inventory | ||||
| Total current assets | $274.51 | $120.54 | $110.27 | $93.8 |
| Long term investments | ||||
| Property, plant & equipment | $4834.33 | $4748.15 | $5036.3 | $4262.68 |
| Goodwill & intangible assets | $314.16 | $418.06 | $519.76 | $519.92 |
| Total noncurrent assets | ||||
| Total investments | $1001.3 | $1081.51 | $864.15 | $642.95 |
| Total assets | $5155.62 | $5096.88 | $5182.71 | $4413.95 |
| Current liabilities | ||||
| Accounts payable | $8.36 | $4.39 | $6.65 | $7.01 |
| Deferred revenue | $905.63 | $844.08 | $789.21 | $774.32 |
| Short long term debt | ||||
| Total current liabilities | $270.48 | $257.27 | $255.11 | $220.3 |
| Long term debt | $1973.04 | $1818.12 | $1911.92 | $1438.85 |
| Total noncurrent liabilities | ||||
| Total debt | $2077.88 | $1923.13 | $2016.88 | $1512.97 |
| Total liabilities | $2266.09 | $2223.9 | $2188.59 | $1670.66 |
| Shareholders' equity | ||||
| Retained earnings | -$1061.29 | -$881.67 | -$776 | -$658.17 |
| Other shareholder equity | $0.72 | $5.18 | -$0.89 | -$5.86 |
| Total shareholder equity | $2763.53 | $2869.72 | $2836.31 | $2641.3 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $695.5 | $606.56 | $135.47 | |
| Cost of revenue | $273.83 | $243.73 | $44.57 | |
| Gross Profit | $421.68 | $362.83 | $90.91 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $26.72 | $23.3 | $7.62 | |
| Total operating expenses | $317.42 | $361.2 | $62.09 | |
| Operating income | $104.25 | $1.64 | $28.81 | |
| Income from continuing operations | ||||
| EBIT | $223.69 | $81.28 | $28.31 | |
| Income tax expense | $2.73 | $13.7 | ||
| Interest expense | $74.91 | $60.91 | $21.51 | |
| Net income | ||||
| Net income | $146.05 | $6.68 | $6.79 | |
| Income (for common shares) | $145.83 | $6.48 | $6.79 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $543.46 | $526.63 | $457.7 | $437.5 |
| Cost of revenue | $182.66 | $171.1 | $137.41 | $128.2 |
| Gross Profit | $360.8 | $355.54 | $320.29 | $309.31 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $38.76 | $40.21 | $37.76 | $33.76 |
| Total operating expenses | $236.78 | $229.85 | $195.97 | $188.22 |
| Operating income | $124.02 | $125.69 | $124.32 | $121.08 |
| Income from continuing operations | ||||
| EBIT | $123.23 | $176.6 | $144.1 | $123.3 |
| Income tax expense | ||||
| Interest expense | $81.35 | $72.23 | $60.14 | $57.18 |
| Net income | ||||
| Net income | $41.88 | $104.37 | $83.97 | $66.12 |
| Income (for common shares) | $41.88 | $104.37 | $83.95 | $64.88 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $146.05 | $6.68 | $6.79 | |
| Operating activities | ||||
| Depreciation | $283.5 | $219.22 | $47.54 | |
| Business acquisitions & disposals | -$10.8 | -$80.17 | -$9.38 | |
| Stock-based compensation | $4.81 | $3.37 | $3.39 | |
| Total cash flows from operations | $316.2 | $152.56 | $67.52 | |
| Investing activities | ||||
| Capital expenditures | $183.06 | -$96.36 | -$19.71 | |
| Investments | $5.08 | $69.1 | -$18.66 | |
| Total cash flows from investing | $119.97 | $187.53 | -$97.78 | -$49.3 |
| Financing activities | ||||
| Dividends paid | -$584.96 | -$210.94 | -$164.2 | -$54.94 |
| Sale and purchase of stock | -$68.15 | -$101.9 | $0.34 | |
| Net borrowings | -$159.1 | $212.14 | -$0.26 | |
| Total cash flows from financing | -$833.92 | -$501.59 | -$66.65 | -$57.21 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $73.02 | $2.14 | -$11.87 | -$38.99 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $41.88 | $104.37 | $83.97 | $66.12 |
| Operating activities | ||||
| Depreciation | $191.09 | $189.64 | $157.87 | $149.59 |
| Business acquisitions & disposals | -$9.32 | -$13.59 | -$9.85 | -$18.57 |
| Stock-based compensation | $15.68 | $15.67 | $15.03 | $12.49 |
| Total cash flows from operations | $273.43 | $258.4 | $247.56 | $233.3 |
| Investing activities | ||||
| Capital expenditures | -$100.3 | -$29.14 | -$658.03 | -$86.66 |
| Investments | $0.13 | $8.38 | $68.66 | -$94.03 |
| Total cash flows from investing | -$114.02 | -$38.47 | -$603.22 | -$201.91 |
| Financing activities | ||||
| Dividends paid | -$220.43 | -$209.42 | -$198.84 | -$187.99 |
| Sale and purchase of stock | $66.18 | $99.28 | $261.89 | $363.87 |
| Net borrowings | $151.03 | -$97.17 | $461.04 | -$198.54 |
| Total cash flows from financing | -$10.36 | -$222.07 | $363.03 | -$31.22 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $149.05 | -$2.15 | $7.36 | $0.16 |
News
Fundamentals
| Market cap | $11.94B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 699.41M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.82 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.15 |
| Quick ratio | N/A |